The decision by more than a dozen European countries to suspend AstraZeneca’s COVID-19 shot faced deepening scrutiny on Wednesday, amid concerns the step could undermine public confidence and delay efforts to beat the coronavirus pandemic.
Coronavirus restrictions were reimposed across much of Italy on Monday, while Ireland and the Netherlands became the latest countries to suspend AstraZeneca's COVID-19 shots over blood clot fears despite the firm and the WHO insisting there is no risk.
Britain will become the first country to roll out the low cost and easily transportable AstraZeneca and Oxford University COVID-19 vaccine on Monday, another step forward in the global response to the pandemic.
British drugmaker AstraZeneca Plc. told Reuters its COVID-19 vaccine should be effective against the new coronavirus variant, adding that studies were under way to fully probe the impact of the mutation.
A top US scientist overseeing COVID-19 vaccine trials expects a large US study to determine how effective AstraZeneca's experimental inoculation is, following perplexing results from other trials released by the company and partner Oxford University.